Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2006-5-1
pubmed:databankReference
pubmed:abstractText
Activin type II receptors (ActRIIs) including ActRIIA and ActRIIB are serine/threonine kinase receptors that form complexes with type I receptors to transmit intracellular signaling of activins, nodal, myostatin and a subset of bone morphogenetic proteins. ActRIIs are unique among serine/threonine kinase receptors in that they associate with proteins having PSD-95, Discs large and ZO-1 (PDZ) domains. In our previous studies, we reported specific interactions of ActRIIs with two independent PDZ proteins named activin receptor-interacting proteins 1 and 2 (ARIP1 and ARIP2). Overexpression of both ARIP1 and ARIP2 reduce activin-induced transcription. Here, we report the isolation of two isoforms of ARIP2 named ARIP2b and 2c. ARIP2, ARIP2b and ARIP2c recognize COOH-terminal residues of ActRIIA that match a PDZ-binding consensus motif. ARIP2 and its isoforms have one PDZ domain in the NH2-terminal region, and interact with ActRIIA. Although PDZ domains containing GLGF motifs of ARIP2b and 2c are identical to that of ARIP2, their COOH-terminal sequences differ from that of ARIP2. Interestingly, unlike ARIP2, overexpression of ARIP2b or 2c did not affect ActRIIA internalization. ARIP2b/2c inhibit inhibitory actions of ARIP2 on activin signaling. ARIP2 is widely distributed in mouse tissues. ARIP2b/2c is expressed in more restricted tissues such as heart, brain, kidneys and liver. Our results indicate that although both ARIP2 and ARIP2b/2c interact with activin receptors, they regulate ActRIIA function in a different manner.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0022-0795
pubmed:author
pubmed:issnType
Print
pubmed:volume
189
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
409-21
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:16648306-Activin Receptors, Type II, pubmed-meshheading:16648306-Activins, pubmed-meshheading:16648306-Adaptor Proteins, Signal Transducing, pubmed-meshheading:16648306-Amino Acid Sequence, pubmed-meshheading:16648306-Animals, pubmed-meshheading:16648306-Brain, pubmed-meshheading:16648306-CHO Cells, pubmed-meshheading:16648306-Calcium-Binding Proteins, pubmed-meshheading:16648306-Cells, Cultured, pubmed-meshheading:16648306-Cricetinae, pubmed-meshheading:16648306-Endocytosis, pubmed-meshheading:16648306-Follicle Stimulating Hormone, pubmed-meshheading:16648306-Isomerism, pubmed-meshheading:16648306-Kidney, pubmed-meshheading:16648306-Liver, pubmed-meshheading:16648306-Membrane Proteins, pubmed-meshheading:16648306-Mice, pubmed-meshheading:16648306-Molecular Sequence Data, pubmed-meshheading:16648306-Myocardium, pubmed-meshheading:16648306-Signal Transduction
pubmed:year
2006
pubmed:articleTitle
Characterization of isoforms of activin receptor-interacting protein 2 that augment activin signaling.
pubmed:affiliation
The Institute for Enzyme Research, University of Tokushima, 3-18-15 Kuramoto, Tokushima 770-8503, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't